{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Kidney+Ischemia&page=2", "query": { "condition": "Kidney Ischemia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Kidney+Ischemia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-11T09:27:00.658Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05218811", "title": "Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Kidney Neoplasms" ], "interventions": [ { "name": "Cryoablation Assisted Partial Nephrectomy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Urological Research Network, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "55 Years to 65 Years" }, "enrollment_count": 150, "start_date": "2020-05-15", "completion_date": "2041-05-15", "has_results": false, "last_update_posted_date": "2023-01-26", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 1, "location_summary": "Miami Lakes, Florida", "locations": [ { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05218811" }, { "nct_id": "NCT02585713", "title": "Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebral Vein Thrombosis", "Deep Vein Thrombosis", "Gonadal Thrombosis", "Hepatic Thrombosis", "Malignant Neoplasm", "Mesenteric Thrombosis", "Metastatic Malignant Neoplasm", "Portal Vein Thrombosis", "Pulmonary Embolism", "Renal Vein Thrombosis", "Splenic Thrombosis", "Venous Thromboembolism" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Dalteparin", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2015-11-20", "completion_date": "2019-12-24", "has_results": true, "last_update_posted_date": "2020-08-04", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 18, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Evanston, Illinois + 15 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02585713" }, { "nct_id": "NCT02341664", "title": "Patient and Provider Assessment of Lipid Management Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hyperlipidemia", "Hypercholesterolemia", "Cardiovascular Disease", "Diabetes", "Chronic Kidney Disease (CKD)", "Hypertension", "Smoking", "Myocardial Infarction (MI)", "Unstable Angina", "Angina", "Coronary Artery Disease (CAD)", "Stroke", "Transient Ischemic Attack (TIA)", "Carotid Stenosis", "Peripheral Arterial Disease", "Atherosclerosis", "Claudication" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7658, "start_date": "2015-05", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2020-03-02", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 14, "location_summary": "Little Rock, Arkansas • San Pedro, California • Ventura, California + 11 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Pedro", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hialeah Gardens", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02341664" }, { "nct_id": "NCT06906055", "title": "Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Peripheral Arterial Disease Below the Knee", "Peripheral Arterial Disease, Rutherford 4 and 5 with Possibility to Improve Vascularization" ], "interventions": [ { "name": "Multicath", "type": "DEVICE" }, { "name": "Standard of Care (SOC)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Summa Therapeutics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 24, "start_date": "2025-04-03", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-04-02", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 2, "location_summary": "Wilmington, Delaware • Vineland, New Jersey", "locations": [ { "city": "Wilmington", "state": "Delaware" }, { "city": "Vineland", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06906055" }, { "nct_id": "NCT05100836", "title": "SURPASS Impella 5.5 Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiogenic Shock", "Acute Decompensated Heart Failure" ], "interventions": [ { "name": "Impella 5.5", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abiomed Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1017, "start_date": "2020-09-21", "completion_date": "2025-05-14", "has_results": false, "last_update_posted_date": "2025-05-20", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 15, "location_summary": "Los Angeles, California • Orlando, Florida • Tampa, Florida + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Evanston", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05100836" }, { "nct_id": "NCT00001313", "title": "Evaluation of Patients With Known or Suspected Heart Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Peripheral Artery Disease", "Coronary Disease", "Diabetes and Heart Failure", "Dilated Cardiomyopathy", "Heart Failure", "Renal Artery Stenosis", "Pulmonary Hypertension" ], "interventions": [], "intervention_types": [], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": null, "start_date": "1992-05-10", "completion_date": "2009-01-06", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 2, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001313" }, { "nct_id": "NCT01476995", "title": "Prognostic Indicators as Provided by the EPIC ClearView", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease", "Congestive Heart Failure", "Valvular Heart Disease", "Atrial Fibrillation", "Hypertension", "Pyelonephritis", "Acute Renal Failure", "Renal Failure", "Viral Hepatitis", "Alcoholic Hepatitis", "Steatohepatitis", "Cirrhosis", "Asthma", "COPD", "Bronchitis", "Emphysema", "Pneumonia", "Inflammatory Bowel Disease", "Crohn's Disease", "Ulcerative Colitis", "Diverticulitis", "Peptic Ulcer Disease", "Irritable Bowel Syndrome", "Cholecystitis", "Pancreatitis", "Malabsorption Disorders", "Celiac Sprue", "Diabetes" ], "interventions": [], "intervention_types": [], "sponsor": "Epic Research & Diagnostics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 353, "start_date": "2010-09", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2011-11-22", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01476995" }, { "nct_id": "NCT02496234", "title": "The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Sapere Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 186, "start_date": "2015-07", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2016-11-23", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02496234" }, { "nct_id": "NCT03347032", "title": "Remote Ischemic Preconditioning for Renal Protection in TAVI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aortic Valve Stenosis", "Renal Insufficiency", "Contrast-induced Nephropathy" ], "interventions": [ { "name": "Remote ischemic preconditioning", "type": "PROCEDURE" }, { "name": "Control", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2018-02-13", "completion_date": "2018-12-30", "has_results": false, "last_update_posted_date": "2022-12-14", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03347032" }, { "nct_id": "NCT04361552", "title": "Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebrovascular Accident", "Chronic Obstructive Pulmonary Disease", "Chronic Renal Failure", "Coronary Artery Disease", "Diabetes Mellitus", "Malignant Neoplasm", "SARS Coronavirus 2 Infection" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Tocilizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2020-04-07", "completion_date": "2020-06-02", "has_results": false, "last_update_posted_date": "2020-06-18", "last_synced_at": "2026-06-11T09:27:00.658Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04361552" } ] }